Please login to the form below

Not currently logged in
Email:
Password:

Celgene names general manager for UK and Ireland

Wim Souverijns replaces Samantha Pearce
Wim Souverijns

Celgene has promoted Wim Souverijns to general manager for its operations in the UK and Ireland.

Souverijns replaces Samantha Pearce, who has moved to a new role at Celgene as VP and general manager for emerging markets in the EMEA region.

Souverijns joined Celgene in 2007 as head of the European marketing operations team. He later moved to a position in the US before returning to Europe to his most recent role as general manager for the Nordics region.

Commenting on his appointment, Souverijns said: “I am excited to have the opportunity to build on recent successes and commit to engage in a collaborative partnership with patients, clinicians, payers and other stakeholders to ensure that all eligible patients have access to our treatments.

“This is even more pertinent with the recent changes to the Cancer Drugs Fund, which I strongly hope will enable patients with myeloma and metastatic pancreatic cancer to continue to be able to access treatments that can make a real difference to their lives.”

Celgene said Souverijns will look to strengthen the firm's relationship with the NHS and other important external partners to highlight the positive effect the industry has on patients and their families.

9th December 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics